Abstract:Objective:To observe the cardioprotective effects of glaucocalyxin A pretreatment on H 2O 2-induced H9c2 cell injury in vitro and predict its mechanisms on apoptosis of H9c2 cardiomyocytes by network pharmacology. Methods:H9c2 cardiomyocytes were randomly divided into blank control group, model group, low-dose group, medium-dose group and high-dose group. The model group was cultured in serum-free medium for 4 h and then intervened with 250 μmol/L H 2O 2 for 6 h. H9c2 cells in the low-dose group, medium dose group and high-dose group were pretreated with 0.125, 0.250, 0.500 μg/ml glaucocalyxin A for 4 hours and then exposed to 250 μmol/L H 2O 2 incubation for 6 hours. The cell viability was measured by MTT assay to determine the effects of glaucocalyxin A. Cell morphology was observed by Hoechst 33258 assay. Flow cytometry analysis of Annexin Ⅴ-FITC/PI staining was used to assess the effects of glaucocalyxin A on H 2O 2-induced H9c2 cell apoptosis. The chemical structure of glaucocalyxin A was obtained by Pubchemistry, its potential targets were predicted by Swiss Target Prediction and Pharmmapper, and its candidate targets against apoptosis in H9c2 cells were screened by GeneCards database. Cytoscape software was used to construct the target network of glaucocalyxin A, meanwhile String database and Cytoscape software were used to plot the protein interaction network, and Metascape database was used for enrichment analysis of GO and KEGG pathways of the target. Results:Compared with the model group, the H9c2 cell viability (66.56% ± 6.51%, 79.21% ± 6.89%, 94.06% ± 5.19% vs. 51.75% ± 4.14%) in the the low-, medium-, high-dose group significantly increased ( P<0.01), the apoptosis rate (24.12% ± 4.71%, 17.42% ± 4.39%, 7.65% ± 1.56% vs. 36.73% ± 5.65%) significantly decreased ( P<0.01). The results of network pharmacology analysis indicated that 22 targets was related to apoptosis of H9c2 cells, and showed that glaucocalyxin A was mainly regulated biological processes of oxidative stress and cell migration, and kinase binding activity. Meanwhile, glaucocalyxin A could regulate to target sites such as MAPK1, VEGFA, MMP9, NOS3, MMP2 and MAPK14, and play an anti-apoptosis role in H9c2 cardiomyocytes. Conclusion:Glaucocalyxin A preconditioning has a protective effect against H 2O 2-induced H9c2 cardiomyocytes injury, and its mechanisms relates to anti-oxidative stress and reducing apoptosis through multi-target and multi-pathway.

Glaucocalyxin A Protects H9c2 Cells Against Hypoxia/Reoxygenation-Induced Injury Through the Activation of Akt/Nrf2/HO-1 Pathway

Protective Effect of Glaucocalyxin A Inhibits H2O2-Induced H9c2 Cardiomyocytes Injury

Protective effects and potential mechanisms of glaucocalyxin A on H 2O 2-induced H9c2 cardiomyocytes

Glaucocalyxin A Ameliorates Hypoxia/Reoxygenation-Induced Injury in Human Renal Proximal Tubular Epithelial Cell Line HK-2 Cells

Glycyrrhizic acid ameliorates myocardial ischemia-reperfusion injury in rats through inhibiting endoplasmic reticulum stress

GLP-1 Agonist Protects Myocardial Hypoxia-Reoxygenation Injury Through PI3K/ Akt Signaling Pathway: an Experimental Study

Glaucocalyxin A inhibits hydrogen peroxide-induced oxidative stress and inflammatory response in coronary artery smooth muscle cells

Gluconolactone Alleviates Myocardial Ischemia/Reperfusion Injury and Arrhythmias via Activating PKC epsilon/Extracellular Signal-Regulated Kinase Signaling

Glycyrrhizin Protects Rat Heart Against Ischemia- Reperfusion Injury Through Blockade of HMGB1- Dependent Phospho-Jnk/bax Pathway

Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat Via Energy Modulation

Hypoxic acclimation improves cardiac redox homeostasis and protects heart against ischemia-reperfusion injury through upregulation of O-GlcNAcylation

Glycyrrhizic acid alleviated MI/R-induced injuries by inhibiting Hippo/YAP signaling pathways

Rhein Protects the Myocardiac Cells Against Hypoxia/reoxygention-Induced Injury by Suppressing GSK3β Activity.

Glucagon-like peptide-1 attenuates endoplasmic reticulum stress–induced apoptosis in H9c2 cardiomyocytes during hypoxia/reoxygenation through the GLP-1R/PI3K/Akt pathways

The protective effects of Glaucocalyxin A on vascular endothelial cells

Glycyrrhizin attenuates myocardial ischemia reperfusion injury by suppressing Inflammation, oxidative stress, and ferroptosis via the HMGB1-TLR4-GPX4 pathway

Protective effect of Hydroxysafflor Yellow A on cerebral ischemia reperfusion-injury by regulating GSK3β-mediated pathways

Kukoamine a Activates Akt/GSK-3β Pathway to Repress Oxidative Stress and Inflammation to Alleviate Myocardial Ischemia-reperfusion Injury

Cinnamaldehyde protects cardiomyocytes from oxygen‐glucose deprivation/reoxygenation‐induced lipid peroxidation and DNA damage via activating the Nrf2 pathway

Asiatic Acid Attenuates Myocardial Ischemia/Reperfusion Injury via Akt/GSK-3β/HIF-1α Signaling in Rat H9c2 Cardiomyocytes

Protective effect of Hydroxysafflor Yellow A on cerebral ischemia reperfusion-injury by regulating GSK3-mediated pathways